MicroPort Scientific : ® Hosts First EMEA Regional Distributor Summit

Amsterdam, the Netherlands - From September 22 to September 23, Shanghai MicroPort Medical (Group) Co ('MicroPort') successfully hosted its first EMEA （Europe，Middle East and Africa） Regional Distributor Summit in Amsterdam. Distributors and potential distributors from 10 countries including Poland, Romania, Sweden, Austria, Greece, Israel and Italy, with Jonathan Chen, MicroPort Senior Vice President of International Operations and Investor Relations and Dr. Linda Lin, MicroPort Vice President of International Business, attended the summit.

Jonathan Chen, MicroPort Senior Vice President of International Operations and Investor Relations, delivered the opening speech for the summit. He introduced to distributors the overview of MicroPort's history, business segments and future development plan with emphasis on its globalization strategy and its international business development. Afterwards, Senior Marketing Manager carried out training on its products including Firehawk Rapamycin Target Eluting Coronary Stent System ('Firehawk'), Firefighter™ PTCA Balloon Dilatation Catheter, PCI accessories, and electrophysiological devices, to enhance distributors' understanding in MicroPort products. In addition, managers of regulatory affairs, finance and operation in the EMEA Region organized compliance training for attendees and introduced the procedures of logistics and customer service in the EMEA Region. Meanwhile, distributors shared the market development in their countries or regions and offered suggestions on how to further expand the markets.

MicroPort's first EMEA Regional Distributor Summit effectively enhanced the distributors' understanding in MicroPort products and strengthened their confidence in cooperation with MicroPort. In the future, MicroPort will continue to work with the overseas distributors to introduce more innovative products to the international markets and provide more ideal solutions to foreign patients.

About MicroPort

MicroPort Scientific Corporation (the 'Group') is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words 'believe', 'intend', 'expect', anticipate', 'project', 'estimate', 'predict', 'is confident', 'has confidence' and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2016 MicroPort Scientific Corporation